Man Group’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-337,271
| Closed | -$13.8M | – | 2129 |
|
|
2024
Q2 | $13.8M | Sell |
337,271
-640,275
| -65% | -$26.2M | 0.03% | 541 |
|
|
2024
Q1 | $41.3M | Buy |
977,546
+885,686
| +964% | +$37.4M | 0.1% | 203 |
|
|
2023
Q4 | $3.89M | Buy |
+91,860
| New | +$3.89M | 0.01% | 980 |
|
|
2023
Q3 | – | Sell |
-152,117
| Closed | -$4.84M | – | 2151 |
|
|
2023
Q2 | $4.84M | Buy |
+152,117
| New | +$4.84M | 0.01% | 874 |
|
|
2022
Q3 | – | Hold |
0
| – | -$321K | – | 2224 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1665 |
|
|
2021
Q2 | – | Sell |
-13,468
| Closed | -$185K | – | 2043 |
|
|
2021
Q1 | $185K | Buy |
+13,468
| New | +$185K | ﹤0.01% | 1754 |
|